Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
Product Classification
Formulation Information
OINTMENT
**DOSAGE AND ADMINISTRATION:** A thin film of DIPROCEL Ointment should be applied to cover completely the affected area once daily, in the morning. DIPROCEL Ointment may also be applied twice daily, in the morning and at night, at the physician’s discretion. As with all highly active topical corticosteroid preparations, treatment should be discontinued when the dermatologic disorder is controlled. According to clinical response, duration of therapy may vary from a few days to a longer period of time. However, treatment should not be continued for more than four weeks without patient re-evaluation.
TOPICAL
Medical Information
**INDICATIONS AND USAGE:** DIPROCEL Ointment is indicated for the relief of the inflammatory manifestations of resistant or severe psoriasis and corticosteroid-responsive dermatoses.
**CONTRAINDICATIONS:** DIPROCEL Ointment is contraindicated in those patients with a history of sensitivity reactions to betamethasone dipropionate, other corticosteroids or to any of the components of DIPROCEL Ointment.
D07AC01
betamethasone
Manufacturer Information
ORGANON SINGAPORE PTE. LTD.
Organon Heist bv
PT Organon Pharma Indonesia Tbk
Active Ingredients
Documents
Package Inserts
Diprocel Ointment PI.pdf
Approved: February 23, 2023